Get the app
HealthcareBusiness & Enterprise4 min reading time

Insilico Medicine Posts First Profit, $106.3M Revenue in First Half of 2026

Unite.AI
Read the full article
Insilico Medicine, a clinical-stage AI drug discovery company, reported its first profit with $106.3M revenue in H1 2026, mainly from dealmaking rather than product sales. Key deals include collaborations with SK Biopharmaceuticals and Takeda Pharmaceutical, supporting its drug pipeline advancement.
#biopharmaceutical-collaborations#clinical-trials#drug-discovery#insilico-medicine#sk-biopharmaceuticals#takeda-pharmaceutical

More in Healthcare

Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)
Healthcare5 min read

Microsoft says its AI tool is better than doctors at diagnosing conditions

Covered by 5 sources